| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.366 | 9.977 | 13.708 | 20.073 | 30.970 |
| Total Income - EUR | - | - | - | - | - | 2.366 | 9.977 | 13.708 | 20.073 | 30.970 |
| Total Expenses - EUR | - | - | - | - | - | 124 | 291 | 315 | 460 | 322 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.242 | 9.686 | 13.393 | 19.613 | 30.648 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.171 | 9.386 | 12.981 | 16.557 | 25.744 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Larmedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 2.242 | 11.609 | 13.113 | 17.809 | 26.407 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 10.695 | 5.054 | 22.522 |
| Cash | - | - | - | - | - | 2.242 | 11.609 | 2.418 | 12.754 | 3.885 |
| Shareholders Funds | - | - | - | - | - | 2.212 | 11.550 | 13.040 | 16.698 | 25.794 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 30 | 59 | 73 | 1.111 | 613 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Larmedica S.r.l.